Xyril

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Xyril

Quick Facts About Xyril

Property Description
Active Ingredient Hydroxyzine
Form Oral (tablet, capsule, solution), Injectable (parenteral)
Pharmacological Class Antihistamine (H1-receptor antagonist)
Origin Synthetic, Piperazine derivative
General Purpose Relief from itching (pruritus) and generalized calming (anxiolytic)

What Type of Medicine is Xyril and What Does it Contain?

Xyril is a synthetic, prescription-only medication primarily classified as a first-generation antihistamine and an anxiolytic agent. The core active ingredient in Xyril is Hydroxyzine, a substance belonging to the piperazine derivative chemical group. This compound exhibits a high affinity for the H1 receptor.

This drug is defined by its ability to modulate activity both systemically and within the central nervous system. Hydroxyzine is typically formulated as the highly soluble dihydrochloride or hydrochloride salt. Xyril is produced as a single-ingredient product and is made available for both oral and intramuscular (IM) routes of administration. Hydroxyzine is recognized for its role in pediatric patients when available as an oral solution, providing a versatile option compared to formulations restricted to adult use.


Understanding the General Purpose of Xyril

The general purpose of Xyril is to provide a dual therapeutic benefit: relief from allergic symptoms and generalized calming relief. Xyril achieves this by acting as an H1-receptor antagonist, effectively blocking the effects of the natural chemical histamine which is responsible for allergic responses like pruritus (itching). This means the medicine works by blocking the receptor that triggers allergic symptoms.

Beyond its anti-allergic capacity, a key benefit is its effect on the central nervous system, classifying it also as an anxiolytic agent. This action produces a sedative or calming effect, making the drug valuable for managing feelings of tension and restlessness. Hydroxyzine is utilized for its soothing properties in dermatological conditions. The core benefit is the systemic reduction of histamine-driven distress combined with the modulation of central activity to induce tranquility.

Regulatory References

  1. Comparative review of antihistamines (NIH)
  2. Summary of Product Characteristics (EMA)

What side effects are possible with Xyril?

Possible side effects and safety information

The safety profile of Xyril (Hydroxyzine) organizes possible adverse reactions based on their frequency of occurrence and the physiological systems affected, as formally documented in government regulatory labeling.

Frequency-Classified Adverse Reactions

The most commonly documented adverse reactions relate primarily to the central nervous system and anticholinergic effects. Adverse reactions are classified by regulatory authorities as follows:

Classification Examples of Documented Adverse Reactions
Common Drowsiness, dry mouth, headache, fatigue.
Uncommon Dizziness, insomnia, agitation, confusion, tremor, nausea.
Rare Hypersensitivity, tachycardia (fast heartbeat), convulsions, hallucinations, urinary retention.
Not Known QT interval prolongation, Torsade de Pointes, Cardiac arrest, Acute Generalized Exanthematous Pustulosis (AGEP).

Serious Safety Considerations

The official labeling includes serious adverse reactions, most notably the risk of QT interval prolongation and Torsade de Pointes, which involve potentially severe irregularities in heart rhythm. Safety constraints formally state that the drug is contraindicated in patients with a known history of acquired or congenital QT interval prolongation or related cardiac risk factors. The use of the drug is recommended by regulatory authorities to be the lowest effective dose for the shortest possible duration.

Population-Specific Safety Notes

Safety statements require explicit modification for specific patient populations. For older adults, the maximum daily dose must be reduced. Individuals with renal or hepatic impairment also require dose adjustments, and the medicine is contraindicated in cases of severe hepatic impairment. Its use is generally contraindicated during the first trimester of pregnancy and throughout lactation.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes a wide range of clinical signs that may manifest in the event of an overdose with Xyril (Hydroxyzine). Given the drug's properties, manifestations can include central nervous system (CNS) effects that range from profound somnolence, stupor, and loss of consciousness to paradoxical symptoms like agitation, confusion, and convulsions. Other documented signs include severe anticholinergic effects such as pronounced dry mouth, tachycardia (increased heart rate), and urinary retention.

Documented Severe Outcomes and Required Actions

The most serious risk documented in official labeling is the potential for severe cardiovascular toxicity, specifically QTc interval prolongation, which may lead to life-threatening ventricular arrhythmias, including Torsades de Pointes. Severe respiratory depression and profound hypotension are also documented outcomes of a severe overdose.

Regulators require that individuals seek immediate medical attention or contact emergency services for any suspected overdose due to the potential for these severe and delayed cardiac complications. There is no specific antidote known for Hydroxyzine overdose. Management must be supportive and symptomatic, with continuous ECG monitoring mandated to assess cardiac rhythm and the QTc interval for an extended period.

Therapeutic Uses of Xyril

The therapeutic domains and symptomatic uses of Xyril cover allergic distress and nervous tension.

Xyril is used to provide symptomatic relief from pruritus (itching) associated with allergic conditions like chronic urticaria and dermatoses, and it is relevant for managing generalized tension and restlessness linked to anxiety. It also plays a supportive role in procedural preparation, assisting with sedation before and after general anesthesia. This use provides a supportive benefit that helps with stability during symptomatic episodes.

“The medicine is relevant for conditions characterized by periods of heightened symptoms, which may involve increased discomfort or tension.”


Managing Symptomatic Domains

The medication is applied across domains where additional symptomatic support is needed. For chronic allergic itching, Xyril contributes to improved comfort by addressing the overall symptom load and helping to maintain functional stability. For anxiety, its anxiolytic property assists with achieving a sense of tranquility when symptoms of nervousness are more noticeable. This allows the medicine to address symptoms related to both physical discomfort and heightened physiological activity.


Quick Fact: Relief for Key Symptom Domains
Primary Symptom Addressed Persistent Allergic Itching (Pruritus)
Secondary Symptom Addressed Nervous Tension and Emotional Restlessness
Contextual Use Sedation for Procedural Preparation

Regulatory References

  1. DailyMed (National Library of Medicine) label for Hydroxyzine

Eligibility and Restrictions for Use

The eligibility to use Xyril (Hydroxyzine) is strictly defined by official government regulatory documents based on patient-specific characteristics and medical conditions. It is approved for use in adults and pediatric patients, with usage established for children generally ge 6 years of age and under 6 years in some regional labels.


Official Contraindications

Xyril is strictly prohibited in the following populations:

Contraindication Basis for Exclusion
Cardiac Risk Known acquired or congenital QT interval prolongation or certain risk factors for ventricular arrhythmia.
Hypersensitivity Known allergy to hydroxyzine, cetirizine, levocetirizine, or any piperazine derivative.
Life Stage Pregnancy (especially early) and Lactation, due to drug transfer.

Use Under Caution or Restriction

  • Geriatric patients (ge 65 years) are generally not recommended for use or require dose reduction due to increased risk of anticholinergic side effects and decreased elimination.
  • Patients with renal or hepatic impairment require dose adjustments due to altered drug metabolism and clearance.
  • Caution is necessary for patients with comorbidities sensitive to anticholinergic effects, such as Angle-closure Glaucoma or conditions causing Urinary Retention.
  • The injectable formulation is contraindicated for Intravenous, Subcutaneous, or Intra-arterial administration routes.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Xyril (Hydroxyzine) defines specific interaction patterns classified by their effect on heart rhythm and central nervous system function. Co-administration with certain medicinal products is contraindicated due to the confirmed risk of QT interval prolongation and subsequent serious cardiac events. This prohibition applies to all other QT/QTc-prolonging drugs and potent inhibitors of CYP3A4/5 enzymes, which are documented to increase Xyril’s blood levels. The use of Xyril is also contraindicated in patients with known cardiac risk factors, such as congenital QT prolongation or uncompensated heart failure, as stated in official labeling.

Pharmacodynamic and Metabolic Interactions

Xyril exhibits a potentiating action that results in additive CNS depressant effects when combined with other Central Nervous System (CNS) depressants, including narcotics and benzodiazepines. Furthermore, the simultaneous use of alcohol is cautioned against in regulatory documents due to this additive CNS depression. From a metabolic standpoint, Xyril acts as an inhibitor of the CYP2D6 enzyme, which may lead to an increase in the plasma concentration of other co-administered medicines that are substrates for this enzyme. Population-specific notes require caution, particularly in elderly patients and those with hepatic impairment, where reduced clearance may increase the risk and severity of these documented interactions.

Mechanism of Action

Xyril is a small molecule that exerts its effect by targeting the osteoclast cells responsible for bone resorption. Specifically, Xyril acts as a competitive inhibitor of the cysteine protease enzyme, cathepsin K. This initial step defines the primary biological target and mechanism of interaction.

This highly specific molecular binding reduces the catalytic function of cathepsin K within the osteoclast's resorption lacuna. By inhibiting this enzyme, Xyril disrupts the cell's ability to cleave and break down collagen and non-collagenous proteins that constitute the bone matrix.

The resulting decrease in enzymatic activity reduces the degradation of the calcified bone matrix and limits the subsequent release of mineral components (e.g., calcium and phosphate) into the bloodstream. This selective mechanism of action, focused on Cathepsin K inhibition, modulates the overall rate of bone resorption without affecting bone formation pathways.

Dosage and Administration Information

How to Use Xyril — Administration Guidelines

This section outlines the administration guidelines for Xyril (Hydroxyzine Hydrochloride).


Administration Scope and Dosing

Scope Item Administration Guidelines
Route of Administration Primarily Oral (tablet, syrup, or suspension). The Intramuscular (IM) route may be used to initiate treatment. Administration is not conducted via intravenous (IV), subcutaneous (SC), or intra-arterial injection.
Standard Dosing The typical adult regimen for conditions like pruritus (itching) often begins with 25 mg at night, increasing as needed to 25 mg three or four times daily in divided doses. The maximum recommended adult daily dose is 100 mg.
Timing Xyril is taken with or without food.

Administration Requirements and Adjustments

Procedural Constraints

The tablet or capsule form is swallowed whole; it is not crushed or chewed. If a dose is missed, the standard practice is to skip the missed dose and take the next dose at the regularly scheduled time, without doubling the dose.

Population-Specific Dosing Rules

Dose reductions apply to certain patient populations:

  • Elderly (Geriatric): The maximum daily dose is restricted to 50 mg per day. The initial starting dose is reduced by half.
  • Hepatic Impairment: The total daily dose is reduced by 33%.
  • Renal Impairment: For patients with moderate or severe kidney function impairment, 50% of the normal dose is administered.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Xyril

This section reviews the types of research and clinical trials that have been conducted on Xyril (Hydroxyzine) as reported in official and peer-reviewed scientific sources. The findings describe group patterns and are not individual predictions.


Evidence for Use in Chronic Pruritus (Itching) and Urticaria

The research exploring Xyril was studied for itching (pruritus) and hives (urticaria) primarily involves short-term Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These studies examined how symptoms change over time in both adults and children, focusing on outcomes related to physical discomfort associated with inflammatory states. Researchers focused on measurements such as changes in pruritus severity scores and urticaria activity scores.

Short-term trials and subsequent analyses reported measurements of how symptoms changed in the observed populations during the initial weeks of treatment. The consistency and weight of evidence for short-term symptomatic change is described as High; however, the majority of the data focuses on episodes where symptoms become more noticeable, and follow-up durations were limited. Evidence quality varies across studies.


Evidence for Use in Generalized Anxiety and Tension

Xyril was evaluated in a number of short-term Randomized Controlled Trials (RCTs), with subsequent systematic reviews exploring its application as an anxiolytic agent for generalized tension and anxiety. These studies primarily focused on adult populations. The research examined outcomes monitoring physiological strain or stress, with the main endpoints being changes on standardized Anxiety Rating Scales and assessments of overall clinical status.

Research findings describe patterns observed in the studies related to changes in certain measured anxiety scale scores during the short study period, usually lasting between 4 and 12 weeks. The official regulatory record highlights a significant gap: there is limited information for long-term outcomes because systematic clinical studies have not fully established the effect of continuous use for periods longer than approximately four months.


What Research Remains Uncertain or Limited

Despite its established uses, the evidence landscape for Xyril presents several clear limitations. Certainty remains low for long-term outcomes for both anxiety and pruritus because follow-up durations were limited in key controlled trials. For anxiety, methodological limitations and high risk of bias was observed in some studies, which affects the overall quality of the evidence. Furthermore, data for certain groups are limited, and comparative evidence is lacking against the newest classes of medications that are now often used as first-line therapy. The research highlights what is known—and what is still uncertain—emphasizing that study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Hydroxyzine Hydrochloride Tablet, film coated (Official Drug Label Information)

Frequently Asked Questions (FAQ)

Common questions about Xyril (FAQ)


Q: How quickly does Xyril usually start working?

According to official product information, the initial effects of Xyril (Hydroxyzine) are typically noted quickly, often within 15 to 30 minutes after taking it by mouth. This fast onset of action is a pattern observed in clinical pharmacology studies.


Q: What makes Xyril different from similar-sounding medicines?

Xyril is distinct because its active ingredient, Hydroxyzine, provides a dual benefit: it acts as both a first-generation antihistamine to treat allergic symptoms and an anxiolytic agent to help with tension. Its chemical structure places it in the piperazine chemical class, which separates it chemically from some other allergy and anxiety medications.


Q: What happens if I forget to take a dose of Xyril?

Official patient information advises that if a dose is missed and it is not almost time for the next scheduled dose, it is advised that the missed dose be taken as soon as it is remembered. However, if it is close to the time for the next dose, the missed dose should be skipped entirely. Doubling up the dose to compensate for the one missed is generally advised against.


Q: Is it normal to feel a specific way when first starting Xyril?

Yes, regulatory documents indicate that drowsiness is a common side effect, especially when first starting treatment. Official reports indicate that this effect may be temporary and may lessen after a few days of use or following a dose adjustment, though individual experience can vary.


Q: How does Xyril interact with grapefruit or grapefruit juice?

Grapefruit and grapefruit juice are substances mentioned in official safety statements. Consuming them can slow down the way your body processes Xyril, potentially increasing the amount of the drug in your system. This increased concentration raises the risk of serious side effects, including changes to your heart rhythm. Official safety information advises against the consumption of grapefruit products with Xyril.


Q: What is meant by 'off-label use' of a drug like Xyril?

Off-label use is when a medicine is used for a purpose, age group, or dosing amount that is not specifically listed or approved by the government regulatory agencies in the official drug labeling. The official documents only support the specific uses listed in the approved indications section.


Q: Are there any specific vitamins or supplements that interact with Xyril?

While most common vitamins do not typically interact, official safety statements caution against taking Xyril with any supplements that can cause sedation (a calming or sleep-inducing effect) or those known to alter your heart rhythm. Consulting with a healthcare professional about all current supplements is the recognized procedure to manage potential interactions.


Q: What are the main things I should discuss with my healthcare provider about Xyril?

Key discussion points noted in regulatory documents include reviewing all current medications and supplements, particularly those that affect heart rhythm or cause drowsiness. It is also important to discuss any history of heart problems (like QT prolongation) and existing liver or kidney impairment, as these factors officially require special consideration or dose adjustment.


Q: Is a generic version of Xyril available?

Yes, generic versions of Xyril's active ingredient, Hydroxyzine, are generally available. These include generic versions of the oral tablet and capsule forms that are reviewed by government agencies for equivalence to the brand name product.


Q: What kind of monitoring is typically required while taking Xyril?

Due to the documented risk of certain heart rhythm issues, such as QT interval prolongation, patients who have existing cardiac risk factors or who are taking interacting medicines may require monitoring. This monitoring may involve checking heart rhythm and blood electrolyte levels, as determined by a healthcare provider.


Q: Are there specific food types to avoid while using Xyril?

The most notable food mentioned in regulatory documents is grapefruit and grapefruit juice, which official information states should be avoided. Avoiding these products is advised because they can increase the drug's concentration in the blood, which raises the risk of serious side effects.


Q: What happens if Xyril is taken in too high a quantity?

The official overdosage section reports that the most common and prominent symptom is hypersedation, which means extreme drowsiness. Other potential signs documented in official labeling include convulsions, stupor, nausea, and vomiting.


Q: Is Xyril similar to other drugs I might have heard of?

Yes, Xyril is classified as a first-generation antihistamine. This places it in the same general therapeutic category as some older, commonly used allergy relief medications.


Q: Is Xyril a controlled substance?

No, Xyril (Hydroxyzine) is not classified as a controlled substance by the government regulatory authorities.


Q: What is the maximum duration of time Xyril is typically used for?

Official regulatory guidelines recommend using the lowest effective dose for the shortest possible duration. For anxiety, studies have not fully established the long-term effects of continuous use for periods longer than approximately four months.


Q: Are there different forms of Xyril available (e.g., tablet, liquid)?

Yes, Xyril is available for oral use in multiple forms, including tablets, capsules, and an oral solution or syrup. This variety allows for options based on patient need.


Q: Can Xyril be used for general wellness or prevention?

Official labeling indicates that Xyril is only approved for the symptomatic relief of specific, diagnosed conditions, such as anxiety, tension, and itching (pruritus). It is not approved or intended for use in general wellness or for preventive health measures.


Q: How is Xyril removed from the body?

Xyril is removed from the body after it is processed (metabolized) mainly by the liver into its active chemical form, called cetirizine. The drug and its breakdown products are then primarily eliminated from the body through the kidneys (via urine).


Q: Is Xyril generally well-tolerated according to official reports?

Official studies and clinical reviews describe the drug’s tolerability. While it is associated with a higher rate of drowsiness (a common side effect) compared to some newer medications, its overall profile is described as comparable to other medicines in its class.


Q: What is the meaning of the dosage strength on the Xyril packaging?

The numerical dosage strength printed on the packaging (e.g., 25 mg) refers to the precise quantity, in milligrams (mg), of the active medicine (Hydroxyzine) contained in each individual tablet, capsule, or specific volume of the liquid form.


Q: What population groups are excluded from using Xyril, based on official documents?

The main groups strictly excluded (contraindicated) include patients with known or congenital heart rhythm problems, those with severe liver or kidney failure, and women who are pregnant (especially in the first trimester) or who are breastfeeding.


Q: What does the patient information leaflet say about Xyril?

Official patient leaflets typically summarize all key regulatory information, including the drug’s purpose, how to use it, the possible side effects, who should not use it (contraindications), and which medicines, foods, or substances must be avoided due to the potential for interaction.


Q: How reliable is the information about Xyril found on different websites?

Official government-sourced documents, such as the FDA Label, EMA Summary of Product Characteristics, or NIH MedlinePlus, are considered the most reliable sources for factual information about Xyril. This information has been formally reviewed and approved by regulatory bodies.


Q: Can Xyril be taken with antacids?

Antacids are a broad category, but official warnings related to QT prolongation risk mean that combining Xyril with certain antacid ingredients, such as famotidine, requires caution. The use of specific antacids can be reviewed with a healthcare professional.

How should Xyril be stored and disposed of?

How to Store and Dispose of Xyril: Official Requirements

Storage and handling of Xyril must strictly follow the official regulatory labeling to maintain the drug’s stability and prevent accidental exposure.


Storage Conditions

Condition Requirement
Temperature Store below 25 C (77 F). Do not freeze.
Protection Keep the product in the original outer carton to protect it from light and moisture.
Child Safety Keep Xyril out of the sight and reach of children at all times.

Stability and Disposal

The medicine is stable until the expiration date only when stored correctly. Once reconstituted, the solution must be stored under refrigeration (2 C to 8 C) and discarded after 28 days.

For disposal, do not flush Xyril down the toilet or throw it in household trash. Return all unused, unwanted, or expired medicine to a government-authorized drug take-back program or collection site.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Xyril found in:

A-Z Index: